入院时临床衰弱量表能否预测脆性髋部骨折患者的30天生存、术后并发症及机构化:一项1255例患者的队列研究
该队列研究纳入1255例65岁以上脆性髋部骨折患者,入院时由临床医生评定临床衰弱量表(CFS)评分,前瞻性审计30天生存、住院并发症、住院时长及新发机构化等结局。CFS与结局呈显著非线性关联,CFS与诺丁汉髋部骨折评分(NHFS)预测30天死亡率的AUC均为0.63(95%CI 0.57至0.69)。作者认为CFS对较健康患者有预测价值,但骨科团队完成CFS未能区分更高衰弱等级,需老年骨科医生参与早期评估。
要点
- CFS 1至5分患者30天死亡风险随评分线性升高,CFS>5分时趋于平台。
- CFS 1至4分患者并发症发生率和住院时长线性升高,CFS>4分时趋于平台。
- 新发机构化风险在CFS 1至8分范围内随评分线性升高。
核心结论
- 使用CFS可能为较健康的髋部骨折患者提供有用的结局信息,但由接诊骨科团队完成CFS未能成功区分定义衰弱的更高CFS等级。
研究设计与样本
- 研究纳入一家机构连续收治的1577例65岁以上脆性髋部骨折患者,其中数据完整的1255例(72%)被分析,临床医生入院时评定CFS评分。
- 审计人员常规前瞻性填写欧洲髋部骨折标准化审计表,记录30天生存、住院并发症、急性住院时长及新发机构化。
- 采用图形化检查结合统计学检验分析CFS与结局的关系,并用受试者工作特征曲线下面积(AUC)比较CFS与诺丁汉髋部骨折评分(NHFS)对30天死亡率的预测价值。
主要发现
- CFS与结局呈显著非线性关联:30天死亡风险在CFS 1至5分线性上升,CFS>5分趋于平台。
- 并发症发生率和住院时长在CFS 1至4分线性上升,CFS>4分趋于平台;新发机构化风险在CFS 1至8分线性上升。
- CFS与NHFS预测30天死亡率的AUC非常相似:CFS AUC 0.63(95%CI 0.57至0.69),NHFS AUC 0.63(95%CI 0.57至0.69)。
关键数值与推荐
- CFS预测30天死亡率AUC 0.63(95%CI 0.57至0.69),NHFS预测30天死亡率AUC 0.63(95%CI 0.57至0.69)。
临床怎么用
- 作者认为,CFS可能为较健康的髋部骨折患者提供有用的结局信息。
- 作者认为,由接诊骨科团队完成CFS未能成功区分更高CFS等级,这强烈支持老年骨科医生在早期评估中发挥作用。
- 作者指出,需要进一步工作以理解为何被评定为轻度、中度和重度衰弱的患者未出现不同结局。
局限性
- 需要进一步工作以理解为何被评定为轻度、中度和重度衰弱的患者未出现不同结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: We assessed the value of the Clinical Frailty Scale (CFS) in the prediction of adverse outcome after hip fracture. METHODS: Of 1,577 consecutive patients aged > 65 years with a fragility hip fracture admitted to one institution, for whom there were complete data, 1,255 (72%) were studied. Clinicians assigned CFS scores on admission. Audit personnel routinely prospectively completed the Standardised Audit of Hip Fracture in Europe form, including the following outcomes: 30-day survival; in-hospital complications; length of acute hospital stay; and new institutionalization. The relationship between the CFS scores and outcomes was examined graphically and the visual interpretations were tested statistically. The predictive values of the CFS and Nottingham Hip Fracture Score (NHFS) to predict 30-day mortality were compared using receiver operating characteristic area under the curve (AUC) analysis. RESULTS: Significant non-linear associations between CFS and outcomes were observed. Risk of death within 30 days rose linearly for CFS 1 to 5, but plateaued for CFS > 5. The incidence of complications and length of stay rose linearly for CFS 1 to 4, but plateaued for CFS > 4. In contrast, the risk of new institutionalization rose linearly for CFS 1 to 8. The AUCs for 30-day mortality for the CFS and NHFS were very similar: CFS AUC 0.63 (95% CI 0.57 to 0.69) and NHFS AUC 0.63 (95% CI 0.57 to 0.69). CONCLUSION: Use of the CFS may provide useful information on outcomes for fitter patients presenting with hip fracture, but completion of the CFS by the admitting orthopaedic team does not appear successful in distinguishing between higher CFS categories, which define patients with frailty. This makes a strong case for the role of the orthogeriatrician in the early assessment of these patients. Further work is needed to understand why patients assessed as being of mild, moderate, and severe frailty do not result in different outcomes. Cite this article: Bone Joint J 2022;104-B(8):980-986.
引用
- Ikram A, Norrish AR, Marson BA, et al. Can the Clinical Frailty Scale on admission predict 30-day survival, postoperative complications, and institutionalization in patients with fragility hip fracture? : a cohort study of 1,255 patients. Bone Joint J. 2022. PMID: 35909371. doi:10.1302/0301-620X.104B8.BJJ-2020-1835.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。